# KAP for Depression in Abstinent Opioid Users

> **NCT05193318** · PHASE2 · TERMINATED · sponsor: **Medical University of South Carolina** · enrollment: 5 (actual)

## Conditions studied

- Opioid Use Disorder, Severe, in Sustained Remission
- Opioid Use Disorder, Severe, in Early Remission
- Major Depressive Disorder

## Interventions

- **DRUG:** Ketamine-assisted psychotherapy

## Key facts

- **NCT ID:** NCT05193318
- **Lead sponsor:** Medical University of South Carolina
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-01-13
- **Primary completion:** 2023-03-20
- **Final completion:** 2023-03-20
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Primary Investigator leaving institution
- **Last updated:** 2024-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05193318

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05193318, "KAP for Depression in Abstinent Opioid Users". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05193318. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*